Defining a role for Hunk in oncogenic signaling

定义 Hunk 在致癌信号传导中的作用

• 批准号: 7330026
• 负责人: Elizabeth S. Yeh
• 金额: $ 4.96万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7330026
• 关键词: Address; Affect; Aggressive behavior; Animals; Biochemical; Breast; Cancer Etiology; Carcinoma; Cell Culture Techniques; Cell Line; Cell Proliferation; Cell Survival; Cellular biology; Cessation of life; Chronic; Colon; Cultured Cells; Defect; Development; Doxycycline; ERBB2 gene; Elements; Estrogens; Exhibits; Family; Family member; Feedback; Gene Expression Profile; Genetic; Genus Cola; Goals; Growth Factor; Health; Homeostasis; Homologous Gene; Human; Human Cloning; In Vitro; Laboratories; Maintenance; Malignant Neoplasms; Mammary Neoplasms; Mammary Tumorigenesis; Mammary gland; Mediating; Modeling; Molecular; Mus; Mutate; Neoplasm Metastasis; Numbers; Oncogene Activation; Oncogenes; Oncogenic; Ovary; Pathway interactions; Phosphotransferases; Physiological; Play; Pregnancy; Progesterone; Protein Kinase; Protein Kinase Inhibitors; Protein Overexpression; Protein-Serine-Threonine Kinases; Role; Role playing therapy; Signal Pathway; Signal Transduction; Signaling Molecule; Stress; System; Techniques; Transgenic Organisms; Transplantation; Woman; base; cell growth; improved; in vivo; insight; lymph nodes; malignant breast neoplasm; member; migration; mouse model; neoplastic; neoplastic cell; novel therapeutics; protein kinase inhibitor; research study; response; therapeutic target; tumor; tumor progression; tumorigenesis

DESCRIPTION (provided by applicant): The goal of this proposal is to understand the mechanism by which Hunk acts intracellularly and determine the role of Hunk protein in tumorigenesis. The first aim of this proposal will address the participation of Hunk in Neu-driven mammary tumorigenesis. These experiments are important to determine the mechanisms by which Neu acts on tumor formation and maintenance. As Neu abberrations are observed in ~30% of human breast cancers, these studies will provide additional insight into the development of more effective treatments. This aim will be addressed using in vivo genetic approaches that employ a mouse model that encorporates an inducible system to drive Neu oncogenesis. These animals will then be crossed with Hunk deficient mice to generate Neu-inducible Hunk wildtype and deficient animals. These animals will be used for long-term chronic induction studies to identify a role for Hunk in tumor latency and multiplicity. In addition, short-term inductions will be performed to characterize the affect of Hunk on Neu-driven cell growth and proliferation. Finally this system will be used to address the role of Hunk in Neu-specific signaling. The second aim of this proposal will address the role of Hunk in PI3K-Akt signaling. As Hunk is a recently discovered protein kinase, little is known about its role as a signaling molecule. However, we have obtained preliminary evidence implicating Hunk in PI3K-Akt signaling. To address the second aim we will employ cell biology and biochemical techniques to establish the relationship between Hunk and PI3K-Akt signaling in the mammary gland. Specifically, we will determine whether a physical interaction exists between Hunk and Akt, whether Hunk is a substrate of Akt, and whether the activation of Akt through PI3K impinges on Hunk protein levels and/or activity. Experiments will also be performed to address the whether Hunk activity and/or levels affect the signaling capacity of Akt through PI3K. Finally, these experiments will include in vivo genetic studies to determine whether Hunk influences Akt-dependent tumorigenesis. The Akt pathway is mutated in many human cancers and, similar to Neu, there is frequently an increase in Akt activity in breast cancers. Consequently, the studies outlined in this proposal are important for understanding the molecular basis of breast cancer and how it can be more effectively treated. It is estimated that breast cancer will be the leading cause of cancer-related death in women in 2006. Several protein kinase inhibitors have been extremely effective for the treatment of human cancer. As such, characterization of novel therapeutic targets is an important element for improving human health.

描述（由申请人提供）：本提案的目的是了解Hunk在细胞内的作用机制，并确定Hunk蛋白在肿瘤发生中的作用。该提案的第一个目的是解决Hunk参与Neu-driven乳腺肿瘤发生的问题。这些实验对于确定Neu作用于肿瘤形成和维持的机制非常重要。由于在约30%的人类乳腺癌中观察到Neu异常，这些研究将为开发更有效的治疗方法提供额外的见解。这一目标将使用体内遗传方法来实现，该方法采用包含诱导系统来驱动Neu肿瘤发生的小鼠模型。然后将这些动物与Hunk缺陷小鼠杂交以产生Neu-inducible Hunk野生型和缺陷动物。这些动物将用于长期慢性诱导研究，以确定Hunk在肿瘤潜伏期和多重性中的作用。此外，将进行短期诱导，以表征Hunk对Neu-driven细胞生长和增殖的影响。最后，该系统将用于解决Neu-specific信号中的Hunk的作用。该提案的第二个目的将解决Hunk在PI 3 K-Akt信号传导中的作用。由于Hunk是一种新近发现的蛋白激酶，其作为信号分子的作用还知之甚少。然而，我们已经获得了暗示Hunk参与PI 3 K-Akt信号传导的初步证据。为了解决第二个目标，我们将采用细胞生物学和生物化学技术来建立乳腺中Hunk和PI 3 K-Akt信号传导之间的关系。具体而言，我们将确定Hunk和Akt之间是否存在物理相互作用，Hunk是否是Akt的底物，以及通过PI 3 K激活Akt是否影响Hunk蛋白水平和/或活性。还将进行实验以解决Hunk活性和/或水平是否影响Akt通过PI 3 K的信号传导能力。最后，这些实验将包括体内遗传研究，以确定Hunk是否影响Akt依赖性肿瘤发生。Akt通路在许多人类癌症中发生突变，与Neu类似，乳腺癌中Akt活性经常增加。因此，本提案中概述的研究对于了解乳腺癌的分子基础以及如何更有效地治疗乳腺癌非常重要。据估计，乳腺癌将是2006年妇女癌症相关死亡的主要原因。几种蛋白激酶抑制剂对治疗人类癌症非常有效。因此，表征新的治疗靶标是改善人类健康的重要因素。